HR 8168 · 116th Congress 2019–2021, ended

Science in Blood Donation Act of 2020

Latest action · Sep 4, 2020 Referred to the House Committee on Energy and Commerce.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 4, 2020
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Science in Blood Donation Act of 2020

This bill requires the Food and Drug Administration (FDA) to revise its guidance on reducing the risk of transmitting by blood transfusion human immunodeficiency virus, hepatitis A, and hepatitis B.

Specifically, the FDA shall update its guidance to remove recommendations to not receive blood donations from a man who had sex with another man in the past three months. The FDA shall also remove recommendations to not receive blood donations from a woman who in the last three months had sex with such a man.

The FDA's updated guidance shall be based on an individual risk assessment of sexual behaviors that evaluate all donors equally without regard to sexual orientation or gender identity.

Cosponsors 16

Members who signed on, in the order they did. Signatures ran from Sep 4, 2020 to Oct 23, 2020; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-ILMike QuigleyOriginalSep 4, 2020
D-NYBrian HigginsSep 11, 2020
D-FLDarren SotoSep 11, 2020
D-DCEleanor Holmes NortonSep 11, 2020
D-WIGwen MooreSep 11, 2020
D-PAMary Gay ScanlonSep 11, 2020
D-GUMichael F. Q. San NicolasSep 11, 2020
D-FLAlcee L. HastingsSep 24, 2020
D-MSBennie G. ThompsonSep 24, 2020
D-PASusan WildSep 24, 2020
D-MEChellie PingreeOct 2, 2020
D-CAGrace F. NapolitanoOct 2, 2020
D-FLAl Lawson, Jr.Oct 9, 2020
D-NJBonnie Watson ColemanOct 9, 2020
D-NYAlexandria Ocasio-CortezOct 23, 2020
D-TXSylvia R. GarciaOct 23, 2020

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Sep 4, 2020

Actions 2

Everything that happened, newest first.

  1. Sep 4, 2020Introduced in House
  2. Sep 4, 2020Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Pursuant to Article I, Section 8.

The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 153, September 4, 2020, page H4325.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require the guidance of the Food and Drug Administration on reducing the risk of human immunodeficiency virus (HIV), hepatitis A, and hepatitis B transmission by blood and blood products (including the donor history questionnaire) to be based on an individual risk assessment of sexual behaviors upon which all donors are evaluated equally, without regard to sexual orientation or gender identity, and for other purposes.
Short Title(s) as Introduced
Science in Blood Donation Act of 2020

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Sep 4, 2020Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.